PILOT AND FEASIBILITY PROGRAM

$296,772P30FY2009DKNIH

Joslin Diabetes Center, Boston MA

Investigators

Linked publications & trials

Paper 39605641 Paper 39435665 Paper 39361612 Paper 39325622 Paper 39322760 Paper 39317751 Paper 39267261 Paper 39264731 Paper 39220302 Paper 39174539 Paper 39143411 Paper 39140975 Paper 39117652 Paper 39003734 Paper 39002127 Paper 38975343 Paper 38935559 Paper 38916421 Paper 38912578 Paper 38864459 Paper 38776390 Paper 38693412 Paper 38693125 Paper 38570632 Paper 38496417 Paper 38457639 Paper 38442155 Paper 38411644 Paper 38409327 Paper 38361627 Paper 38315503 Paper 38131378 Paper 38039147 Paper 38032738 Paper 37998535 Paper 37987887 Paper 37983524 Paper 37905018 Paper 37895214 Paper 37852413 Paper 37822597 Paper 37808767 Paper 37796982 Paper 37794253 Paper 37773161 Paper 37759604 Paper 37753251 Paper 37732504 Paper 37720527 Paper 37717845 Paper 37708415 Paper 37667837 Paper 37660951 Paper 37611129 Paper 37595843 Paper 37583558 Paper 37577492 Paper 37522857 Paper 37503212 Paper 37503007 Paper 37485354 Paper 37479789 Paper 37473635 Paper 37468583 Paper 37467433 Paper 37462036 Paper 37441495 Paper 37409234 Paper 37398386 Paper 37396182 Paper 37392854 Paper 37379803 Paper 37365586 Paper 37354909 Paper 37339634 Paper 37327334 Paper 37292813 Paper 37292780 Paper 37286033 Paper 37271372 Paper 37233759 Paper 37230214 Paper 37226675 Paper 37223066 Paper 37216639 Paper 37186836 Paper 37160100 Paper 37146281 Paper 37120574 Paper 37083018 Paper 37058471 Paper 37058410 Paper 37046360 Paper 37036212 Paper 37022232 Paper 37022120 Paper 36993342 Paper 36933618 Paper 36924359 Paper 36917606

Abstract

The overall goal of the Pilot and Feasibility Study Program is to enrich the scientific base of the DERC at Joslin as well as to enhance research on types 1 and 2 diabetes and their complications more generally. This goal can be achieved through bringing in talented new investigators or by taking up promising new experimental strategies or methods. Therefore, the program has traditionally provided support to three types of researchers: a. beginning investigators in the diabetes field who have not yet received substantial NIH funding;tx seasoned investigators in the diabetes field who wish to strike out in a novel direction;and a investigators from other fields embarking on a diabetes-related project for the first time.

View original record on NIH RePORTER →